Showing results (151-160 of 164) with videos related to

Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2000
Disease-free survival advantage of adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with node-negative, rapidly proliferating breast cancer: a randomized multicenter studyD Amadori, O Nanni, M Marangolo, et al.
Biomed Research International|September 23, 2014
New biomarkers to predict the evolution of in situ breast cancersS Bravaccini, M M Tumedei, E Scarpi, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 10, 2008
Role of p53 codon 72 arginine allele in cell survival in vitro and in the clinical outcome of patients with advanced breast cancerI Vannini, W Zoli, A Tesei, et al.
Current Cancer Drug Targets|May 25, 2010
In vitro and in vivo antitumor efficacy of docetaxel and sorafenib combination in human pancreatic cancer cellsP Ulivi, C Arienti, W Zoli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 1998
Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: a randomized, controlled studyC Oberhoff, B Neri, D Amadori, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2006
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the Italian tamoxifen anastrozole (ITA) trialF Boccardo, A Rubagotti, P Guglielmini, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 10, 1997
Evaluation of the cost of home care for terminally ill cancer patientsM Maltoni, C Travaglini, M Santi, et al.
Breast Cancer Research and Treatment|December 12, 2018
Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trialO Nanni, D Amadori, A De Censi, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|March 1, 1996
Guidelines on artificial nutrition versus hydration in terminal cancer patients. European Association for Palliative CareF Bozzetti, D Amadori, E Bruera, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 7, 2016
Gastric GISTs: Analysis of c-Kit, PDGFRA and BRAF mutations in relation to prognosis and clinical pathological characteristics of patients - A GIRCG studyL Capelli, E Petracci, V Quagliuolo, et al.
Pageof 17